Effect of chemical mutagens and carcinogens on gene expression profiles in human TK6 cells. 2012

Lode Godderis, and Reuben Thomas, and Alan E Hubbard, and Ali M Tabish, and Peter Hoet, and Luoping Zhang, and Martyn T Smith, and Hendrik Veulemans, and Cliona M McHale
Occupational, Environmental and Insurance Medicine, Katholieke Universiteit Leuven, Leuven, Belgium. Lode.Godderis@med.kuleuven.be

Characterization of toxicogenomic signatures of carcinogen exposure holds significant promise for mechanistic and predictive toxicology. In vitro transcriptomic studies allow the comparison of the response to chemicals with diverse mode of actions under controlled experimental conditions. We conducted an in vitro study in TK6 cells to characterize gene expression signatures of exposure to 15 genotoxic carcinogens frequently used in European industries. We also examined the dose-responsive changes in gene expression, and perturbation of biochemical pathways in response to these carcinogens. TK6 cells were exposed at 3 dose levels for 24 h with and without S9 human metabolic mix. Since S9 had an impact on gene expression (885 genes), we analyzed the gene expression data from cells cultures incubated with S9 and without S9 independently. The ribosome pathway was affected by all chemical-dose combinations. However in general, no similar gene expression was observed among carcinogens. Further, pathways, i.e. cell cycle, DNA repair mechanisms, RNA degradation, that were common within sets of chemical-dose combination were suggested by clustergram. Linear trends in dose-response of gene expression were observed for Trichloroethylene, Benz[a]anthracene, Epichlorohydrin, Benzene, and Hydroquinone. The significantly altered genes were involved in the regulation of (anti-) apoptosis, maintenance of cell survival, tumor necrosis factor-related pathways and immune response, in agreement with several other studies. Similarly in S9+ cultures, Benz[a]pyrene, Styrene and Trichloroethylene each modified over 1000 genes at high concentrations. Our findings expand our understanding of the transcriptomic response to genotoxic carcinogens, revealing the alteration of diverse sets of genes and pathways involved in cellular homeostasis and cell cycle control.

UI MeSH Term Description Entries
D009153 Mutagens Chemical agents that increase the rate of genetic mutation by interfering with the function of nucleic acids. A clastogen is a specific mutagen that causes breaks in chromosomes. Clastogen,Clastogens,Genotoxin,Genotoxins,Mutagen
D002273 Carcinogens Substances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included. Carcinogen,Oncogen,Oncogens,Tumor Initiator,Tumor Initiators,Tumor Promoter,Tumor Promoters,Initiator, Tumor,Initiators, Tumor,Promoter, Tumor,Promoters, Tumor
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D005786 Gene Expression Regulation Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control (induction or repression) of gene action at the level of transcription or translation. Gene Action Regulation,Regulation of Gene Expression,Expression Regulation, Gene,Regulation, Gene Action,Regulation, Gene Expression
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D016000 Cluster Analysis A set of statistical methods used to group variables or observations into strongly inter-related subgroups. In epidemiology, it may be used to analyze a closely grouped series of events or cases of disease or other health-related phenomenon with well-defined distribution patterns in relation to time or place or both. Clustering,Analyses, Cluster,Analysis, Cluster,Cluster Analyses,Clusterings
D058977 Molecular Sequence Annotation The addition of descriptive information about the function or structure of a molecular sequence to its MOLECULAR SEQUENCE DATA record. Gene Annotation,Protein Annotation,Annotation, Gene,Annotation, Molecular Sequence,Annotation, Protein,Annotations, Gene,Annotations, Molecular Sequence,Annotations, Protein,Gene Annotations,Molecular Sequence Annotations,Protein Annotations,Sequence Annotation, Molecular,Sequence Annotations, Molecular
D020869 Gene Expression Profiling The determination of the pattern of genes expressed at the level of GENETIC TRANSCRIPTION, under specific circumstances or in a specific cell. Gene Expression Analysis,Gene Expression Pattern Analysis,Transcript Expression Analysis,Transcriptome Profiling,Transcriptomics,mRNA Differential Display,Gene Expression Monitoring,Transcriptome Analysis,Analyses, Gene Expression,Analyses, Transcript Expression,Analyses, Transcriptome,Analysis, Gene Expression,Analysis, Transcript Expression,Analysis, Transcriptome,Differential Display, mRNA,Differential Displays, mRNA,Expression Analyses, Gene,Expression Analysis, Gene,Gene Expression Analyses,Gene Expression Monitorings,Gene Expression Profilings,Monitoring, Gene Expression,Monitorings, Gene Expression,Profiling, Gene Expression,Profiling, Transcriptome,Profilings, Gene Expression,Profilings, Transcriptome,Transcript Expression Analyses,Transcriptome Analyses,Transcriptome Profilings,mRNA Differential Displays

Related Publications

Lode Godderis, and Reuben Thomas, and Alan E Hubbard, and Ali M Tabish, and Peter Hoet, and Luoping Zhang, and Martyn T Smith, and Hendrik Veulemans, and Cliona M McHale
January 2012, PloS one,
Lode Godderis, and Reuben Thomas, and Alan E Hubbard, and Ali M Tabish, and Peter Hoet, and Luoping Zhang, and Martyn T Smith, and Hendrik Veulemans, and Cliona M McHale
July 2010, Mutation research,
Lode Godderis, and Reuben Thomas, and Alan E Hubbard, and Ali M Tabish, and Peter Hoet, and Luoping Zhang, and Martyn T Smith, and Hendrik Veulemans, and Cliona M McHale
August 1973, Science (New York, N.Y.),
Lode Godderis, and Reuben Thomas, and Alan E Hubbard, and Ali M Tabish, and Peter Hoet, and Luoping Zhang, and Martyn T Smith, and Hendrik Veulemans, and Cliona M McHale
January 1982, Ecology of disease,
Lode Godderis, and Reuben Thomas, and Alan E Hubbard, and Ali M Tabish, and Peter Hoet, and Luoping Zhang, and Martyn T Smith, and Hendrik Veulemans, and Cliona M McHale
April 1986, Chemical & pharmaceutical bulletin,
Lode Godderis, and Reuben Thomas, and Alan E Hubbard, and Ali M Tabish, and Peter Hoet, and Luoping Zhang, and Martyn T Smith, and Hendrik Veulemans, and Cliona M McHale
September 1991, Mutagenesis,
Lode Godderis, and Reuben Thomas, and Alan E Hubbard, and Ali M Tabish, and Peter Hoet, and Luoping Zhang, and Martyn T Smith, and Hendrik Veulemans, and Cliona M McHale
January 1986, Progress in clinical and biological research,
Lode Godderis, and Reuben Thomas, and Alan E Hubbard, and Ali M Tabish, and Peter Hoet, and Luoping Zhang, and Martyn T Smith, and Hendrik Veulemans, and Cliona M McHale
November 1981, Archives of environmental contamination and toxicology,
Lode Godderis, and Reuben Thomas, and Alan E Hubbard, and Ali M Tabish, and Peter Hoet, and Luoping Zhang, and Martyn T Smith, and Hendrik Veulemans, and Cliona M McHale
January 1975, Neoplasma,
Lode Godderis, and Reuben Thomas, and Alan E Hubbard, and Ali M Tabish, and Peter Hoet, and Luoping Zhang, and Martyn T Smith, and Hendrik Veulemans, and Cliona M McHale
January 1966, Progress in nucleic acid research and molecular biology,
Copied contents to your clipboard!